Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.

Volker Kunzmann, Jens T Siveke, Hana Algül, Eray Goekkurt, Gabriele Siegler (Co-author), Uwe Martens, Dirk Waldschmidt, Uwe Pelzer, Martin Fuchs, Frank Kullmann, Stefan Boeck, Thomas J Ettrich, Swantje Held, Ralph Keller, Ingo Klein, Christoph-Thomas Germer, Hubert Stein (Co-author), Helmut Friess, Marcus Bahra, Ralf JakobsIngo Hartlapp, Volker Heinemann

Research output: Contribution to journalOriginal Articlepeer-review

121 Citations (Web of Science)
Original languageEnglish
Pages (from-to)12-138
JournalLANCET GASTROENTEROLOGY & HEPATOLOGY
Volume6
Issue number2
DOIs
Publication statusPublished - 2021

Keywords

  • NEOADJUVANT THERAPY
  • CHEMORADIOTHERAPY
  • GUIDELINES

Cite this